Phillip Sharp and John Carroll at Endpoints 11 (Michael Last for Endpoints News)
June 16, 2025 09:56 AM EDT
Startups
Editor's note

Help us find 2025's best biotech star­tups: Nom­i­na­tions are open for End­points 11

John Carroll

Editor & Founder

I’d bet that some­time in the past few years, you’ve heard of an ex­cep­tion­al­ly promis­ing pri­vate biotech com­pa­ny that checked all the box­es for po­ten­tial …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

For­mer CEO Anne Wo­j­ci­c­ki wins bid for 23andMe

Lil­ly to bol­ster gene edit­ing pipeline, buy­ing Verve for up to $1.3B

Iso­mor­phic to open US of­fice in Cam­bridge, hires ex-Re­lay CMO

Im­muneer­ing says MEK pill beats stan­dard of care in first-line pan­cre­at­ic can­cer

Up­dat­ed: Sage's roller coast­er ends in $561M ac­qui­si­tion by Su­per­nus

sponsored

This com­pa­ny has spent a decade in­no­vat­ing NGS-based com­pan­ion di­ag­nos­tics world­wide–what’s next?

A service from the Financial Times